ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 27 filers reported holding ENVVENO MEDICAL CORPORATION in Q2 2024. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $207,213 | +1.6% | 39,469 | +5.3% | 0.00% | – |
| Q1 2024 | $203,951 | +4.0% | 37,491 | -1.7% | 0.00% | – |
| Q4 2023 | $196,045 | +17.0% | 38,141 | +22.7% | 0.00% | – |
| Q3 2023 | $167,516 | +61.4% | 31,079 | -7.8% | 0.00% | – |
| Q2 2023 | $103,805 | -35.6% | 33,703 | -2.2% | 0.00% | – |
| Q1 2023 | $161,235 | -6.5% | 34,452 | +1.9% | 0.00% | – |
| Q4 2022 | $172,431 | -18.3% | 33,810 | +0.4% | 0.00% | – |
| Q3 2022 | $211,000 | +66.1% | 33,664 | +0.8% | 0.00% | – |
| Q2 2022 | $127,000 | -48.0% | 33,410 | -13.1% | 0.00% | – |
| Q1 2022 | $244,000 | -0.8% | 38,441 | +2.9% | 0.00% | – |
| Q4 2021 | $246,000 | – | 37,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $1,025,762 | 0.19% |
| Perceptive Advisors | 781,615 | $3,657,958 | 0.11% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 24,000 | $112,320 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 177,610 | $840,095 | 0.02% |
| Financial Perspectives, Inc | 3,278 | $15,340 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 83,083 | $392,982 | 0.00% |
| Newbridge Financial Services Group, Inc. | 20 | $94 | 0.00% |
| BlackRock Finance, Inc. | 34,452 | $161,235 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 43,192 | $204,298 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,559 | $7 | 0.00% |